The FDA Approved A New ADHD Medication For Kids. Here’s What Parents Should Know.
Scary Mommy
The FDA has approved Simtriyo, a new ADHD medication containing centanafadine that uniquely targets norepinephrine, dopamine, and serotonin to treat patients aged six and older. Although it is classified as having non-stimulant characteristics and may offer fewer side effects like appetite suppression and insomnia compared to traditional stimulants, experts note that established stimulant medications remain more effective for symptom relief. Consequently, this drug is expected to serve primarily as an alternative for patients who experience problematic side effects from first-line stimulant treatments rather than a superior primary option.
All articles from 25 August 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.